DJ AbbVie Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ rallied 1.17% to $211.48 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.76% to 5,849.72 and Dow Jones Industrial Average falling 1.48% to 43,191.24.
This was the stock's third consecutive day of gains.
AbbVie Inc. hit a new 52-week high, surpassing its previous peak of $209.60, which the company achieved on February 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.37% to $167.28, Pfizer Inc. $(PFE)$ fell 0.68% to $26.25, and Amgen Inc. $(AMGN)$ rose 0.88% to $310.78.
Trading volume (7.0 M) eclipsed its 50-day average volume of 6.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 03, 2025 16:32 ET (21:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。